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Abstract
Our aim in this study was to evaluate how the chemical stability of silver nanoparticles
(SNs) influences their efficacy against Candida albicans and C. glabrata biofilms. Several
parameters of SN stability were tested, namely, temperature (50oC, 70oC, and 100oC), pH
(5.0 and 9.0), and time of contact (5 h and 24 h) with biofilms. The control was defined as
SNs without temperature treatment, pH 7, and 24 h of contact. These colloidal suspen-
sions at 54 mg/L were used to treat mature Candida biofilms (48 h) formed on acrylic.
Their efficacy was determined by total biomass and colony-forming unit quantification.
Data were analyzed using analysis of variance and the Bonferroni post hoc test (α = 0.05).
The temperature and pH variations of SNs did not affect their efficacy against the viable
cells of Candida biofilms (P > 0.05). Moreover, the treatment periods were not decisive in
terms of the susceptibility of Candida biofilms to SNs. These findings provide an impor-
tant advantage of SNs that may be useful in the treatment of Candida-associated denture
stomatitis.
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Introduction
Candida-associated denture stomatitis is frequent in el-
derly people, especially those who wear complete dentures,
and is one of the most common forms of oral candidia-
sis [1,2]. Even though Candida albicans is strongly asso-
ciated with the development of denture stomatitis, non-
C. albicans Candida species, such as C. glabrata, may
also contribute to this pathological condition [3,4]. Can-
dida species form biofilms on acrylic denture surfaces that
C©TheAuthor 2014. Published byOxfordUniversity Press onbehalf of The International Society for HumanandAnimalMycology.
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are characterized by networks of yeasts, pseudohyphae,
and hyphae surrounded by an extracellular matrix [5]
and embedded mainly into irregularities of acrylic sur-
faces [6]. Unlike C. albicans, C. glabrata do not form
hyphae [7].
Although antifungal suspensions that are based on
nystatin, amphotericin B, miconazole, and fluconazole
have been widely used to treat denture stomatitis [8,9],
Candida infections are frequently recalcitrant to conven-
tional treatments [1,10–12]. Indeed, established Candida
biofilms are more resistant to antimicrobial agents than
their planktonic counterparts [13,14]. This serious clinical
impact of increased resistance to conventional antifungal
therapy has strengthened the search for alternative strate-
gies that could contribute significantly to the prevention and
destruction ofCandida biofilm formation. For this purpose,
silver nanoparticles (SNs) are recognized as a new class of
antimicrobial agents [15] because of their effective antimi-
crobial ability. SNs have a large surface area and high reac-
tivity compared with microparticles [16]. In dentistry, these
nanoparticles have been incorporated into dental adhesives
[17,18] and resin composites [19] in order to inhibit dental
caries and into denture base acrylic resin [20] in order to
prevent stomatitis.
The mechanisms of killing microorganisms of SNs are
multifactorial [15,16,21–23], and it is believed that these
mechanisms are similar to those of silver ions (SIs) [21,24].
In general, SNs bind to sulfur-containing proteins in bi-
ological molecules, resulting in defects in the microbial
cell membrane and loss of intracellular contents; inhibition
of respiratory chain enzymes; and binding to phosphorus-
containing compounds such as DNA, preventing cell re-
production [15,16,21–23]. The targets of action of SNs
have been relatively well described in complex studies
[21–23,25].
Recently, it was demonstrated that SNs affected the ex-
tracellular matrix composition and structure of Candida
biofilms [26] and exhibited synergistic antibiofilm activity
when combined with either nystatin or chlorhexidine diglu-
conate [27]. In light of the therapeutic potential of SNs,
one essential aspect that remains to be established is the
impact of the chemical stability of SNs on their efficacy
against Candida biofilms. Variables such as temperature,
ionic strength, and nature of the immersion medium (com-
position and pH) may influence the size, rate of dissolution,
aggregation, and stability of SNs [28–30]. The loss of chem-
ical stability could cause aggregation of SNs and reduction
of their effectiveness against biofilms. Thus, our aim in this
study was to evaluate how the chemical stability of silver
nanoparticles (SNs) influences their efficacy against Can-
dida albicans and C. glabrata biofilms.
Materials and methods
Synthesis and characterization of silver colloidal
nanoparticles
SNs were synthesized in accordance with a previously de-
scribed procedure [28]. Briefly, 5.0 × 10−3 mol/l silver ni-
trate (Merck KGaA, Darmstadt, Germany) was reduced by
the addition of 0.3 mol/l sodium citrate (Merck KGaA).
The solution turned amber yellow and a colloidal suspen-
sion was formed. Then, the silver colloids were stabilized by
the addition of 1.4 mol/l ammonia (Merck KGaA). SN sus-
pensions were characterized by ultraviolet/visible (UV/vis)
spectroscopy (Shimadzu MultSpec-1501 spectrophotome-
ter; Shimadzu Corporation, Tokyo, Japan) and by trans-
mission electron microscopy (FEG-VP Supra 35 electron
microscope; Carl Zeiss, Jena, Germany). The typical ab-
sorption spectrum of SNs, centered at 430 nm, was located
in the UV/vis spectrum; electron micrograph images dis-
played spherical SNs with an average particle size of 5 nm
[14,31]. The SN concentration of 54 mg/l used in this study
was based on its efficacy against Candida biofilms reported
in previous studies [14,26,31].
Chemical stability of SNs through temperature
and pH variations
Chemical stability assays were carried out at room temper-
ature based on the method of Ellis et al. [32], with some
modifications. For the temperature stability assay, stock
suspensions of SNs in glass tubes were placed in a water
bath at 50oC (SN-50), 70oC (SN-70), and 100oC (SN-100)
for 30min. The resultant SN colloidal suspensionswere also
characterized by UV/vis spectroscopy as cited above. Later,
SN suspensions (preheated) were diluted in Roswell Park
Memorial Institute (RPMI) 1640 medium (Sigma-Aldrich,
St. Louis, MO, USA) to achieve a silver concentration of
54 mg/l.
For the pH stability assay, the pH of the SN suspensions
at 54 mg/l (diluted in RPMI 1640 medium) was adjusted
to pH 5.0 (SN-pH 5) or pH 9.0 (SN-pH 9) using solu-
tions of 1 M hydrochloric acid and 1 M sodium hydroxide,
respectively. After 2 h at room temperature, the pH was
readjusted to pH 7.0.
Substrate preparation
The substrate used for biofilm formation was denture
acrylic resin. For standardization of acrylic resin speci-
mens, a stainless steel matrix with internal molds was fixed
with wax (Wilson, Sa˜o Paulo, Brazil) on a glass plate with
a rough surface (to mimic the roughness of the palate)
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and invested in metallic flask with type III dental stone
(Herodent, Petro´polis, Brazil). After the dental stone set,
the flask halves were separated, the wax was removed, and
the matrix molds and glass plate were cleaned. The denture
resin (QC20; Dentsply Ind. e Com. Ltd., Petro´polis, Brazil)
was manipulated, packed, pressed into the matrix molds,
and polymerized according to the manufacturer’s recom-
mendations. After bench cooling at room temperature, the
specimens (10 × 10 × 3 mm) were deflasked, and the ex-
cess resin was removed with a bur (Maxi-Cut; Maillefer SA,
Ballaigues, Switzerland). The acrylic specimens were then
rinsed with deionized water, dried at room temperature,
and sterilized [5].
Artificial saliva medium
Artificial saliva (AS; pH 6.8) was the medium used for
biofilm formation [33]. Its composition was as follows:
2 g of yeast extract (Sigma-Aldrich), 5 g of peptone (Sigma-
Aldrich), 2 g of glucose (Synth, Diadema, Brazil), 1 g of
mucin (Sigma-Aldrich), 0.35 g of sodium chloride (Merck
KGaA), 0.2 g of calcium chloride (Sigma-Aldrich), and 0.2 g
of potassium chloride (Merck KGaA) per 1 l of deionized
water.
Yeast strains and growth conditions
Two strains of C. albicans and C. glabrata were tested. In
addition to the reference C. albicans (American Type Cul-
ture Collection [ATCC] 10231) and C. glabrata (ATCC
90030), two Candida oral clinical isolates were used,
namely, C. albicans 324LA/94 (obtained from the culture
collection of Cardiff Dental School, Cardiff, UK) and C.
glabrata D1 (obtained from the Biofilm Group of the Cen-
tre of Biological Engineering, University of Minho, Braga,
Portugal).
All yeast strains were grown aerobically on Sabouraud
glucose agar medium (SGA; Difco, Le Pont de Claix,
France) at 37oC for 24 h. A loopful of the Candida colonies
from SGA plates was inoculated into Sabouraud glucose
broth (SGB; Difco) medium and incubated at 37oC for
20–24 h under agitation (120 rpm). After being harvested
by centrifugation (6500 g for 5 min at 15oC), cell pellets
were washed twice in phosphate-buffered saline (PBS; pH 7,
0.1M) and the cellular density adjusted to 1 × 107 cells/ml
in AS, using a Neubauer hemocytometer. These Candida
cell suspensions were used in the subsequent biofilm forma-
tion assays.
Biofilm formation and treatment with SNs
Candida biofilms were formed on acrylic resin specimens
according to Silva et al. [5]. Briefly, acrylic specimens were
placed in 24-well microtiter plates (Costar, Tewksbury,
USA) and 1 ml of the standardized Candida cell suspen-
sion (1 × 107 cells/ml in AS) was added to each well and
incubated at 37oC for 48 h under agitation (120 rpm). Af-
ter 24 h, 500 µl of AS was removed and an equal volume
of fresh AS was added. Following Candida biofilm forma-
tion (48 h), AS was removed and the acrylic specimens
were washed once with 1 ml of PBS to remove nonadherent
cells. Then, 1 ml of 54 mg/l SNs (with temperature and pH
variations, as previously described) diluted in RPMI 1640
medium was added to the preformed Candida biofilms and
incubated at 37oC for 24 h under agitation (120 rpm).
For positive and negative controls, Candida biofilms were
preformed on acrylic specimens and then incubated with
54 mg/l of SNs without temperature and pH variations and
with RPMI 1640 medium without SNs, respectively.
To evaluate the influence of the length of treatment
on the susceptibility of Candida biofilms to SNs, Candida
biofilms (48 h) formed on acrylic specimens were incubated
at 37oC (120 rpm) with 1 ml of RPMI 1640 medium con-
taining SNs diluted at 54 mg/l (without temperature and
pH variations) for 5 h and 24 h. These treatment periods
were the same as those used by Harrison et al. [34] to ex-
amine the ability of Candida biofilms to survive exposure
to various toxic metal ions. After each treatment period
(5 h and 24 h), acrylic specimens were washed once with
1 ml of PBS to remove nonadherent cells. Controls devoid
of SNs were also included.
Quantification of total biofilm biomass
Total biomass of Candida biofilms exposed to SNs (with or
without temperature and pH variation) was measured using
the crystal violet (CV) staining method [5,31]. Briefly, after
the treatment period, acrylic specimens were washed once
with 1 ml of PBS to remove loosely attached cells. Then,
Candida biofilms were fixed with 1 ml of 99% methanol
(Sigma-Aldrich). After 15 min, methanol was removed and
the acrylic specimens were allowed to dry at room tem-
perature. Next, 1 ml of CV stain (1% v/v; Merck KGaA)
was added to each well containing acrylic specimens and
incubated for 5 min. Acrylic specimens were gently washed
with deionizedwater, dried at room temperature, and trans-
ferred to new 24-well microtiter plates. Then, 1 ml of acetic
acid (33% v/v; Sigma-Aldrich) was added to remove the
CV stain from the biofilms. Last, absorbance of the ob-
tained solution was measured in a microtiter plate reader
(Eon microplate spectrophotometer; BioTek, Winooski,
VT, USA) at 570 nm and standardized in relation to the
area of acrylic specimens (Abs/cm2). The assays were per-
formed independently three times in triplicate.
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Quantification of biofilm viable cells
Cultivable Candida cells from biofilms exposed to SNs
(with or without temperature and pH variation) were enu-
merated by counting colony-forming units (CFUs). Acrylic
specimens were washed once with PBS, immersed in 1 ml
of PBS in falcon tubes, sonicated for 30 s at 40 W, and
vortexed for 5 min. Serial decimal dilutions (in PBS) of
each biofilm cell suspension were plated on SGA, and the
plates were incubated at 37oC. After 24 h, the total number
of colony-forming units per unit area (Log10 CFU/cm2) of
acrylic specimens was enumerated. The experiments were
performed independently three times in triplicate.
Statistical analysis
The data for each test were analyzed statistically using
one-way analysis of variance and the Bonferroni post hoc
test, using SPSS software (Statistical Package for the So-
cial Sciences, Inc., Chicago, IL, USA) with significance level
denoted at P < 0.05.
Results
The absorption spectra for the nonheated SNs (Fig. 1A),
SN-50 (Fig. 1B), and SN-70 (Fig. 1C) were similar and
demonstrated plasmon bands centered at approximately
430 nm. For SN-100, the absorption peak was attained
at approximately 500 nm (Fig. 1D).
With reference to biofilm biomass quantification, Figure
2A shows that preheating of the SN suspension to 100oC
impaired its efficacy only for C. albicans 324LA/94. In
this case, SN-100 produced a significant increase (42.9%;
P = 0.037) in the total biomass compared with the posi-
tive control group. The results displayed in Figure 3A in-
dicate that for both strains of C. glabrata, the variation in
pH significantly impaired the efficacy of SNs in reducing
total biomass. When the SN-pH 5 group was compared
with the positive control, increases in the total biomass of
C. glabrata ATCC 90030 and C. glabrata D1 of 42.9%
(P = 0.036) and 25% (P = 0.045), respectively, were ob-
served. In addition, when the pH was changed to 9.0, the
total biomass increased approximately 38% (P= 0.036) for
C. glabrata ATCC 90030 and 39% (P = 0.009) for C.
glabrata D1 compared with the positive control.
As shown in Figure 4A, C. albicans ATCC 10231,
C. albicans 324LA/94, C. glabrata ATCC 90030, and
C. glabrata D1 biofilms treated with SNs for 5 h showed
significant reductions in total biomass of 47.2% (P <
0.001), 35.8% (P< 0.001), 51.5% (P< 0.001), and 36.8%
(P < 0.001), respectively, compared with their respective
controls (5 h without SN).When these biofilms were treated
for 24 h, the reductions in the total biomass compared with
the control groups were also significant for all strains as
follows: C. albicans ATCC 10231: 18.5%, P = 0.011;
C. albicans 324LA/94: 32.3%, P < 0.001; C. glabrata
ATCC 90030: 22.3%, P = 0.001; and C. glabrata D1:
17.6%, P = 0.027. Although the 5-h treatment resulted in
a higher reduction in total biomass than the 24-h treatment,
the difference between these treatments was only significant
for C. glabrata ATCC 90030 (P = 0.001).
In terms of biofilm cultivable cell quantification, Figures
2B and 3B clearly show that the temperature and pH vari-
ations neither impaired nor improved significantly the effi-
cacy of SNs against Candida biofilms. On the other hand,
the treatments with SNs for 5 h and 24 h (Fig. 4B) produced
significant decreases in the number of colony-forming units
only for C. albicans 324LA/94 (reduction of 1.44-log10;
P < 0.001) and C. glabrata D1 (reduction of 0.71-log10;
P = 0.034), respectively, compared with the controls. The
comparison between the two treatment periods was statisti-
cally significant only for C. albicans 324LA/94 (P< 0.001),
with better results for the shorter treatment period (5 h).
Discussion
There are few reports on how the chemical stability of SNs
influences antimicrobial properties. Here, our goal was to
determine whether heating or changing the pH of a SN
stock solution and whether varying the treatment period
would affect the antifungal activity of SNs against Can-
dida biofilms. Clinically, SNs could be used in mouth-
washes and as a disinfectant solution for soaking dentures.
Therefore, in the present study, these nanoparticles were
heated to 50oC, 70oC, and 100oC. These higher tempera-
tures were used because storage temperatures for colloidal
suspensions in some tropical countries and desert regions
can exceed 50oC. Moreover, 100oC was chosen to repre-
sent an extreme condition and was close to the tempera-
ture used to synthesize SNs. Preheating SNs to 50oC, 70oC,
and 100oC had no significant influence on total biomass
or cell viability of Candida biofilms (Fig. 2). The only ex-
ception was the C. albicans 324LA/94 biomass, where SNs
heated to 100oC induced a 42.9% increase in total biomass
in relation to the no-heated group (positive control). In an
attempt to explain these findings, additional tests were per-
formed to verify the behavior of the SN suspension when
subjected to heating.
Aliquots of each SN suspension heated to 50oC, 70oC,
and 100oC were evaluated using UV/vis spectroscopy
(Fig. 1). Surprisingly, SN-50 and SN-70 suspensions did not
show extreme changes in their spectral absorption aspects
when compared with the nonheated SN suspension, indicat-
ing that these suspensions remained stable after 30 min of
heating. This is in agreement with results for total biomass
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Figure 1. Ultraviolet/visible spectra of colloidal suspensions of silver nanoparticles not heated (A) and heated to 50oC (B), 70oC (C), and 100oC (D).
and cultivable biofilm cells obtained for SN-50, SN-70, and
the control (SN without heating) and explains why there
were no significant differences among these groups.
Kittler et al. [29] evaluated the dissolution in water of
SNs stabilized with citrate and polyvinylpyrrolidone for up
to 125 days at 5oC, 25oC, and 37oC. They found that SNs
dissolved partially into ions and that an increase in temper-
ature caused an increase in the degree of dissolution and
release of SIs. As a result of this process, a considerable
increase in the toxicity of SNs was observed. In the present
study, although the nanoparticles were heated to high tem-
peratures, the short heating period (30 min) may have been
insufficient to a significantly dissolve these particles and re-
lease large amounts of SIs, in turn, improving antibiofilm
activity. It must be emphasized that the SNs used in our
studywere well stabilized with ammonia. Ammonia’s role is
to trap all SIs present in the colloidal suspension by forming
soluble diamine silver complexes; these complexes prevent
the growth of already-formed SNs as well as the formation
of new nanoparticles [28].
However, heating the SN suspension to 100oC changed
the suspension’s color and the particle size distribution.
This is shown in Figure 1D by the shift of the absorption
peak maximum towards a higher wavelength and the peak
broadening of the UV-vis spectra. This might indicate that
the SN-100 suspension was significantly destabilized, lead-
ing to the formation of silver aggregates or new nanoparti-
cles [35]. However, the efficacy of the SN-100 suspension
against Candida biofilms was significantly reduced only for
the C. albicans 324LA/94 biomass. Unfortunately, there is
no feasible explanation for this finding. These results point
to the fact that the storage of colloidal suspension at high
temperatures may not compromise the effectiveness of SNs
against Candida biofilms. Perhaps, this is due to the inher-
ent tendency for SN agglomeration when in contact with
biofilms [26,36].
Regarding the tests performed to evaluate the efficacy of
SN suspensions with a change in pH, it is important to note
that pH 5.0 was chosen because it is close to the average pH
of saliva from patients with denture stomatitis [37]; pH 9.0
was arbitrarily chosen as representative of a basic pH. After
adjusting the pH (to 5.0 or 9.0) of SN colloidal suspensions
diluted in RPMI 1640 medium, dark aggregates or flocs
settled on the vessel bottom, indicating instability of the
colloidal suspensions at both acidic and basic pH. For this
reason, UV/vis spectroscopy analysis was not performed.
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Figure 2. (A) Mean values of the absorbance per square centimeter obtained with crystal violet staining assay and (B) means of the logarithm of
colony-forming units per square centimeter for mature Candida biofilms (48 h) after 24 h of treatment with silver nanoparticles (SNs) at 54 mg/L that
were preheated to 50oC (SN-50), 70oC (SN-70), and 100oC (SN-100). Positive control (PC), biofilms incubated with unheated SNs. Negative control
(NC), biofilms incubated with Roswell Park Memorial Institute 1640 medium without SNs. Error bars represent standard deviation of the mean.
Asterisk (∗) denotes P < 0.05, using analysis of variance followed by the Bonferroni test.
Figure 3. (A) Mean values of the absorbance per square centimeter obtained with crystal violet staining assay and (B) means of the logarithm of
colony-forming units per square centimeter for mature Candida biofilms (48 h) after 24 h of treatment with silver nanoparticles (SNs) at 54 mg/L that
had the pH varied (during 2 h) to 5.0 (SN-pH 5) and 9.0 (SN-pH 9) before contact with biofilms. Positive control (PC), biofilms incubated with SNs
without pH variation. Negative control (NC), biofilms incubated with Roswell Park Memorial Institute 1640 medium without SNs. Error bars represent
standard deviation of the mean. Asterisk (∗) denotes P < 0.05, using analysis of variance followed by the Bonferroni test.
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Figure 4. (A) Absorbance values per square centimeter obtained with crystal violet staining assay and (B) means of the logarithm of colony-forming
units per square centimeter for mature Candida biofilms (48 h) after different treatment periods with silver nanoparticles at 54 mg/L. Error bars
indicate standard deviation of the mean. Asterisk (∗) denotes P < 0.05, using analysis of variance followed by the Bonferroni test.
According to Kittler et al. [29], the dissolution behavior
of nanoparticles in biological medium is definitely more
complex and distinct from that in water due to the presence
of several organic compounds in the medium. RPMI 1640
medium contains substantial amounts of glucose, amino
acids, and proteins. Thus, the addition of hydrochloric acid
or sodium hydroxide probably led to a destabilization in the
colloidal suspension and favored the release of SIs, which
may have bound to proteins or precipitated in the RPMI
medium as silver chloride [38], silver phosphate [29], or
silver hydroxide.
The results also demonstrate that the variation in pH did
not impair or improve significantly the efficacy of SNs on
the number of colony-forming units (Fig. 3B). The reasons
for this are related to those mentioned above regarding the
effect of temperature stability on the antifungal activity of
SNs. However, the pH changes resulted in significant in-
creases in the total biomass of C. glabrata ATCC 90030
and C. glabrata D1 when compared with the positive con-
trols (Fig. 3A). As C. albicans biofilms are more profuse
and produce greater amounts of extracellular matrix than
C. glabrata biofilms [7,39], the nanoparticles and some ag-
gregates were likely retained in the matrix and did not reach
the cells that were in the deeper layers of the biofilm. If this
is the case, it is possible that the contact of aggregates with
their cells may have been facilitated in C. glabrata ATCC
90030 and C. glabrata D1 biofilms. Although it did not
result in a decrease in the number of viable cells (probably
due to SN aggregation), it might have generated a stress
response in the biofilm cells; the cells responded by pro-
ducing more matrix, since the number of viable cells was
similar. The lack of correlation between both methods used
for biofilm quantification was not surprising, given that the
two methods assessed different biofilm features and are ac-
cepted as complementary. While CV staining quantified the
total biofilm biomass (extracellular matrix and both liv-
ing and dead cells), the CFU enumeration determined the
number of cultivable cells.
Additionally, by comparing the treatment periods
(5 h and 24 h), there were differences for the biomass
of C. glabrata ATCC 90030 biofilm and for the number
of colony-forming units of C. albicans 324LA/94 biofilm,
with better results for the shorter treatment period for all
(Fig. 4). It is likely that the exposure period (5 h) was too
short to cause a large aggregation of SNs, in turn, facilitat-
ing their antimicrobial action. From a clinical perspective,
these results are important because shorter exposures to
SNs could prevent the harm that is related to silver toxicity
for mammalian cells. What should be considered are the
inherent physiological differences among the species and
strains tested [39]. For instance, biofilms formed by C. al-
bicans normally have a thin basal yeast layer and a thicker
hyphal layer (less compact), whereas C. glabrata biofilms
are characterized by a compact monolayer or multilayer
of yeasts [39]. These features may hinder or facilitate the
action of SN against C. albicans and C. glabrata biofilms.
Based on the results of our study, the use of stabilized
or destabilized SNs may not be crucial to how SNs affect
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against Candida biofilms. Additional research to elucidate
the longevity of SN formulation, especially under oral tem-
perature and pH conditions, is needed. In addition, research
on the toxicological effects that result when nanoparticles
are changed by environmental variations is needed. More-
over, studies on the incorporation of SNs into acrylic resin
and on the physical, mechanical, and microbiological prop-
erties of the nanocomposites generated are also necessary in
order to develop biomaterials that will prevent or control
Candida-associated denture stomatitis.
In summary, the results indicate that temperature and
pH variations of SNs did not affect their efficacy against
the sessile cells of Candida biofilms. Furthermore, the treat-
ment periods were not decisive in terms of the susceptibility
to SNs, and the shorter treatment period might be clinically
advantageous. Accordingly, these results provide important
insights that could be useful in the treatment of Candida-
associated denture stomatitis with formulations and bioma-
terials containing SNs.
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